Formation Bio

New York, United States Founded: 2016 • Age: 10 yrs
AI-powered drug discovery platform for various diseases
Request Access

About Formation Bio

Formation Bio is a company based in New York (United States) founded in 2016 by Benjamine Liu and Linhao Zhang.. Formation Bio has raised $608 million across 4 funding rounds from investors including Sanofi, Spark Capital and ArrowMark Partners. Formation Bio offers products and services including Drug Development Platform. Formation Bio operates in a competitive market with competitors including Incyte, LEO Pharma, Flexion Therapeutics, Owkin and AbSci, among others.

  • Headquarter New York, United States
  • Founders Benjamine Liu, Linhao Zhang
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $608 M (USD)

    in 4 rounds

  • Latest Funding Round
    $372 M (USD), Series D

    May 21, 2024

  • Investors
    Sanofi

    & 12 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Formation Bio

Formation Bio offers a comprehensive portfolio of products and services, including Drug Development Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Accelerates drug development using AI for efficient clinical trials

People of Formation Bio
Headcount 50-200
Employee Profiles 44
Board Members and Advisors 6
Employee Profiles
People
Ben Liu
CEO & Co-Founder
People
Enrique García-Rivera
Senior Director, Data Science
People
Jennifer Kang
Senior Director, Program Management
People
Nishan Senthirajah
Manager, Strategic Finance

Unlock access to complete

Board Members and Advisors
people
Don Degolyer
Advisor
people
Rehan Verjee
Advisor

Unlock access to complete

Funding Insights of Formation Bio

Formation Bio has successfully raised a total of $608M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $372 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series D — $372.0M
  • First Round
  • Investors Count 13
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2024 Amount Series D - Formation Bio Valuation a16z
Sep, 2021 Amount Series C - Formation Bio Valuation

investors

Jun, 2018 Amount Series B - Formation Bio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Formation Bio

Formation Bio has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Sanofi, Spark Capital and ArrowMark Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
Founded Year Domain Location
Philanthropic assets are managed by Willett Advisors LLC.
Founded Year Domain Location
Sequoia Capital is engaged in venture capital investments.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Formation Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Formation Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Formation Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Formation Bio

Formation Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Flexion Therapeutics, Owkin and AbSci, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Developer of drugs for treating dermatology diseases
domain founded_year HQ Location
Developer of therapies for the treatment of musculoskeletal disorders
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-based technology is used for recombinant protein production in therapeutics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Formation Bio

Frequently Asked Questions about Formation Bio

When was Formation Bio founded?

Formation Bio was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Formation Bio located?

Formation Bio is headquartered in New York, United States. It is registered at New York, New York, United States.

Who is the current CEO of Formation Bio?

Benjamine Liu is the current CEO of Formation Bio. They have also founded this company.

Is Formation Bio a funded company?

Formation Bio is a funded company, having raised a total of $608M across 4 funding rounds to date. The company's 1st funding round was a Series B of $80M, raised on Jun 01, 2017.

What does Formation Bio do?

AI-powered drug discovery platform for various diseases. The company leverages technology such as LLMs and the modern data stack in novel ways to efficiently design and operate clinical development in Atopic Dermatitis, Chronic Hand Eczema, and Knee Osteoarthritis.

Who are the top competitors of Formation Bio?

Formation Bio's top competitors include Owkin, Flexion Therapeutics and LEO Pharma.

What products or services does Formation Bio offer?

Formation Bio offers Drug Development Platform.

Who are Formation Bio's investors?

Formation Bio has 13 investors. Key investors include Sanofi, Spark Capital, ArrowMark Partners, Andreessen Horowitz, and Willett Advisors.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available